Investor Relations

OPKO Licensee TESARO Receives FDA Approval for VARUBI™ (rolapitant) more »

OPKO Letter to Shareholders more »

OPKO Health to Be Present at the Barrington Research Fall Investment Conference more »

OPKO Completes Acquisition of Bio-Reference Laboratories more »

Conferences & Events

Upcoming Events
Details on upcoming events are not yet available.

Archived Event
Sep 1, 2015 OPKO Senior Management to be present at the Barrington Research Fall Investment Conference
PDF View Presentation  1.6 MB
Show Additional Information

Chicago, IL